Business Context and Reporting Period
This Form 8-K Current Report was filed by electroCore, Inc. on December 20, 2022. The filing addresses a critical regulatory event regarding the continued listing of the Company's common stock on the Nasdaq Capital Market.
Key Financial Metrics
This filing is a current report regarding a listing status event and does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. Investors should refer to the Company's most recent Form 10-K or 10-Q for financial performance details.
Material Changes and Events
- Nasdaq Non-Compliance: The Company received a determination letter from Nasdaq stating its common stock failed to maintain a minimum bid price of $1.00 per share for 10 consecutive trading days, violating Nasdaq Listing Rule 5550(a)(2).
- Delisting Risk: If the Company does not request a hearing by 4:00 p.m. Eastern Time on December 27, 2022, trading will be suspended on December 29, 2022, and the stock will be delisted.
- Appeal Process: The Company intends to request an appeal hearing. During the appeal, trading will continue, and delisting will be stayed pending the Panel's decision.
Guidance, Outlook, and Management Commentary
- Compliance Plan: To regain compliance, the Company is prepared to seek stockholder authorization for a reverse stock split.
- Special Meeting: A definitive proxy statement was filed on December 23, 2022, for a special meeting of stockholders scheduled for February 13, 2023, to vote on the Reverse Stock Split Proposal.
- Contingency: If delisted from Nasdaq, the Company expects its stock to trade on an OTC Markets Group marketplace.
- Uncertainty: Management states there can be no assurance that the Nasdaq Hearings Panel will grant the suspension of delisting or that the reverse stock split will be approved in time to prevent delisting.
Investor Verification Checklist
- Verify the outcome of the Nasdaq Hearings Panel regarding the suspension of delisting.
- Confirm the date and results of the Special Meeting of stockholders scheduled for February 13, 2023, regarding the reverse stock split.
- Monitor the daily bid price of the stock to assess ongoing compliance with Nasdaq rules.
- Review the Company's latest Form 10-K for financial health and risk factors not detailed in this 8-K.